OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SLHN57

Swiss Life Holding AG

Life & Health InsuranceVerified

Swiss Life Holding AG has a basic and diluted share count of 27.95 million shares outstanding, indicating no dilution pressure from share-based compensation or convertible instruments. The company's liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents. The company's profitability and returns are not available in the current dataset, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without disclosed operating margins, ROIC, or EBITDA, it is not possible to evaluate performance against peers in the Life & Health Insurance industry. Swiss Life Holding AG's geographic and segment exposure is not disclosed in the available data, making it impossible to assess revenue concentration or segment performance. The company's business model is not segmented in the provided information. The company's growth trajectory is not quantifiable due to the absence of revenue history and outlook numeric deltas. Analysts have assigned a mean price target of 849.82 CHF and a median price target of 850.00 CHF, with a mean recommendation of 3.14 (Hold). The company's risk assessment indicates low dilution risk and unknown liquidity risk. No dilution sources are disclosed in the available data, and no adjustments are applied in custom valuations. Recent events, filings, and transcripts are not disclosed in the available data, precluding an analysis of material developments or management commentary.

30-day price · SLHN(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySwiss Life Holding AG
TickerSLHN.S
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Swiss Life Holding AG provides life and health insurance products and services in Switzerland and internationally.

Classification. Swiss Life Holding AG is classified in the Financials economic sector, Insurance business sector, and Life & Health Insurance industry with 92% confidence.

Swiss Life Holding AG has a basic and diluted share count of 27.95 million shares outstanding, indicating no dilution pressure from share-based compensation or convertible instruments. The company's liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents. The company's profitability and returns are not available in the current dataset, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without disclosed operating margins, ROIC, or EBITDA, it is not possible to evaluate performance against peers in the Life & Health Insurance industry. Swiss Life Holding AG's geographic and segment exposure is not disclosed in the available data, making it impossible to assess revenue concentration or segment performance. The company's business model is not segmented in the provided information. The company's growth trajectory is not quantifiable due to the absence of revenue history and outlook numeric deltas. Analysts have assigned a mean price target of 849.82 CHF and a median price target of 850.00 CHF, with a mean recommendation of 3.14 (Hold). The company's risk assessment indicates low dilution risk and unknown liquidity risk. No dilution sources are disclosed in the available data, and no adjustments are applied in custom valuations. Recent events, filings, and transcripts are not disclosed in the available data, precluding an analysis of material developments or management commentary.
Key takeaways
  • Swiss Life Holding AG operates in the Life & Health Insurance industry with 92% classification confidence.
  • The company has no dilution pressure from share-based compensation or convertible instruments.
  • Analysts assign a mean price target of 849.82 CHF and a median price target of 850.00 CHF.
  • The company's liquidity risk could not be assessed due to missing balance-sheet inputs.
  • No revenue concentration or segment performance data is available in the current dataset.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCHF
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.78B$1.25B$980.0M
FY-3$2.29B$1.18B$444.0M
FY-2$3.63B$1.09B$209.0M
FY-1$621.0M$1.23B$272.0M
FY0$3.83B$1.23B$251.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$240.42B$16.40B$6.37B
FY-3$213.44B$9.09B$6.91B
FY-2$213.44B$8.17B$5.89B
FY-1$218.93B$7.52B$5.05B
FY0$219.12B$7.31B$5.27B
PeriodOCFCapExFCFSBC
FY-4$296.0M-$89.0M$980.0M
FY-3$986.0M-$83.0M$444.0M
FY-2$881.0M-$109.0M$209.0M
FY-1$186.0M-$130.0M$272.0M
FY0$1.70B-$107.0M$251.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricSLHNActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity27.5% medp25 4.7% · p75 66.5%
Observations
IR observations
Mean price target849.82 CHF
Median price target850.00 CHF
High price target939.00 CHF
Low price target760.00 CHF
Mean recommendation3.14 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count3.00
Hold count6.00
Sell count5.00
Strong-sell count0.00
Mean EPS estimate47.37 CHF
Last actual EPS43.47 CHF
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 06:57 UTC#a041199c
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 11:30 UTCJob: 06cec245